Key result
Arrhythmias are frequent in COVID-19 due to systemic inflammation, hypoxia, and drugs, with QT prolongation playing a central role requiring strict monitoring.
Why the study?
Cardiovascular manifestations and arrhythmias frequently develop and cause death in patients with COVID-19, requiring clinicians to understand their management.
This review highlights the increased incidence of various arrhythmias in COVID-19 patients and emphasizes the importance of strict QT duration monitoring.
Answers are grounded in this paper and cite their sources.
May prompt stricter QT surveillance in COVID-19; leaves open optimal protocols pending prospective trials.
Coronavirus disease-2019 (COVID-19) disease is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus infection and firstly appeared in China and then became a pandemic. The leading cause of mortality is respiratory failure in COVID-19; however, cardiovascular manifestations are frequent and also important causes of death in COVID-19. The incidence of arrhythmia is increased in patients with COVID-19 due to increased systemic inflammatory response, hypoxia, and administered drugs. All kinds of arrhythmias, including bradyarrhythmias, supraventricular and ventricular arrhythmias, may develop during COVID-19 course. QT prolongation plays a central role in COVID-19 related arrhythmias. Therefore, QT duration should be strictly followed. All the clinicians should know the management of arrhythmias that they might face with frequently during the pandemic.
No takes yet. Share an insight, caveat, or question.
Şener et al. (2022) conducted a review in COVID-19 and Arrhythmias. Arrhythmias are frequent in COVID-19 due to systemic inflammation, hypoxia, and drugs, with QT prolongation playing a central role requiring strict monitoring.
Synapse has enriched 10 related papers. Consider them for comparative context: